GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Korea Arlico Pharm Co Ltd (XKRX:260660) » Definitions » Shiller PE Ratio

Korea Arlico Pharm Co (XKRX:260660) Shiller PE Ratio : 9.76 (As of Apr. 13, 2025)


View and export this data going back to 2018. Start your Free Trial

What is Korea Arlico Pharm Co Shiller PE Ratio?

As of today (2025-04-13), Korea Arlico Pharm Co's current share price is ₩4665.00. Korea Arlico Pharm Co's E10 for the fiscal year that ended in Dec24 was ₩477.81. Korea Arlico Pharm Co's Shiller PE Ratio for today is 9.76.

The historical rank and industry rank for Korea Arlico Pharm Co's Shiller PE Ratio or its related term are showing as below:

XKRX:260660' s Shiller PE Ratio Range Over the Past 10 Years
Min: 7.16   Med: 7.73   Max: 10.72
Current: 9.37

During the past 10 years, Korea Arlico Pharm Co's highest Shiller PE Ratio was 10.72. The lowest was 7.16. And the median was 7.73.

XKRX:260660's Shiller PE Ratio is ranked better than
87.81% of 525 companies
in the Drug Manufacturers industry
Industry Median: 23.25 vs XKRX:260660: 9.37

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Korea Arlico Pharm Co's adjusted earnings per share data of for the fiscal year that ended in Dec24 was ₩-357.000. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is ₩477.81 for the trailing ten years ended in Dec24.

Shiller PE for Stocks: The True Measure of Stock Valuation


Korea Arlico Pharm Co Shiller PE Ratio Historical Data

The historical data trend for Korea Arlico Pharm Co's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Korea Arlico Pharm Co Shiller PE Ratio Chart

Korea Arlico Pharm Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 7.23

Korea Arlico Pharm Co Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - 7.23

Competitive Comparison of Korea Arlico Pharm Co's Shiller PE Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Korea Arlico Pharm Co's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Korea Arlico Pharm Co's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Korea Arlico Pharm Co's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Korea Arlico Pharm Co's Shiller PE Ratio falls into.


;
;

Korea Arlico Pharm Co Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Korea Arlico Pharm Co's Shiller PE Ratio for today is calculated as

Shiller PE Ratio=Share Price/ E10
=4665.00/477.81
=9.76

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Korea Arlico Pharm Co's E10 for the fiscal year that ended in Dec24 is calculated as:

For example, Korea Arlico Pharm Co's adjusted earnings per share data for the fiscal year that ended in Dec24 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Dec24 (Change)*Current CPI (Dec24)
=-357/121.1352*121.1352
=-357.000

Current CPI (Dec24) = 121.1352.

Korea Arlico Pharm Co Annual Data

Earnings per Share (Diluted) CPI Adj_EPS
201512 1,779.683 100.220 2,151.082
201612 253.333 101.561 302.158
201712 339.048 102.991 398.780
201812 83.810 104.351 97.291
201912 638.095 105.121 735.301
202012 370.000 105.765 423.768
202112 327.000 109.676 361.164
202212 532.000 115.179 559.510
202312 104.000 118.837 106.011
202412 -357.000 121.135 -357.000

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Korea Arlico Pharm Co  (XKRX:260660) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Korea Arlico Pharm Co Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Korea Arlico Pharm Co's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Korea Arlico Pharm Co Business Description

Traded in Other Exchanges
N/A
Address
7-21, Baumoe-ro 27-gil, Seocho-gu, Seoul, KOR
Korea Arlico Pharm Co Ltd is engaged in the business of manufacturing and selling pharmaceuticals products. The company offers products in the area of the circulatory system, antiplatelet, muscle relaxants, diabetes, antibiotic and chemotherapy, allergy and respiratory disease, ointment, vitamin and health supplements, digestive system, and metabolic disease. It provides products in various forms such as tablets, capsules, gel, and cream.

Korea Arlico Pharm Co Headlines

No Headlines